Health industries

Breaking ground in the Pharma Industry: A new reporting framework for vendor risk


For pharma companies and their vendors, third party compliance can be grueling and costly. Adopting a standardized, independent assurance and reporting framework can drastically reduce costs and provide more confidence in their vendors’ operations.

Three years in, the ACA marketplace shows modest premium growth, fewer plan options and continued competition


As carriers become more knowledgeable about who they are insuring and how to navigate tight regulations, they are refining their product offerings and the market is beginning to settle.

Top health industry issues of 2016 - Webcast replay


This recorded webcast focuses on the 10 business issues outlined in PwC's Top health industry issues of 2016 report, including merger mania, the new money managers, new databases improving patient care and consumer health, and more.

Healthcare, Higher Education, and Nonprofit Series: Hot topics and technical updates impacting accounting and financial reporting - Webcast replay


In this recorded webcast focusing on emerging accounting developments affecting not-for-profit organizations, we will cover recent FASB standard setting developments that have occurred since our October webcast. As always, the focus is on not-for-profit organizations that apply FASB standards, with an emphasis on healthcare and higher education institutions.

Top health industry issues of 2016


HRI’s annual Top health industry issues report highlights the forces that are expected to have the most impact on the industry in the coming year, with a glance back at key trends from the past decade.

FASB Income tax projects update – A PLS perspective


In this alert, we provide a pharmaceutical and life sciences perspective to the FASB Income tax projects update.

Rx Marketplace Quarterly, Issue 8


The PwC Rx Marketplace Quarterly features a wide range of financial reporting developments, accounting and tax developments, regulatory updates and general industry trends impacting the pharmaceutical and life sciences industry.

Pharmaceutical and Life Sciences Tax Hot Topics: Recent US and Global Tax Policy Developments and Year-End Tax Accounting Considerations - Webcast replay


The first segment of this recorded webcast features a tax policy update, including the political and economic factors driving US and global tax policy in 2016 and beyond. The second segment provides highlights of tax accounting matters pharmaceutical and life sciences companies should consider when preparing their annual income tax provision.

Health industries: 2015 SEC comment letter trends


To help registrants gain insight into the SEC’s current areas of interest, PwC analyzed comments released by the SEC staff to domestic large accelerated, accelerated and non-accelerated registrants within the healthcare provider industry.

Healthcare, Higher Education, and Nonprofit Series: Year End Review and 2016 Outlook - Webcast replay


In this webcast, our tax specialists discuss key areas impacting healthcare providers including academic medical centers, universities, and other tax-exempt organizations.